Healthcare -
Biotechnology - NASDAQ - US
$ 5.78
4.14 %
$ 180 M
Market Cap
-2.17
P/E
ACRV - RESEARCH & DEVELOPMENT
Research & Development ACRV - Acrivon Therapeutics, Inc. Common Stock
45.5 M
LAST VALUE
82.10%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR